Intraperitoneal Bioavailability
Intraperitoneal Bioavailability is the fraction of an administered drug that reaches the systemic circulation via the intraperitoneal route, distinguished from other routes by its specific absorption dynamics across the peritoneal membrane.
291
Publications
12.4K
Citations
1.5K
Authors
494
Institutions
Publications per year
2017–2026
50
291
Pharmacokinetic rationale for peritoneal drug administration in the treatment of ovarian cancer.
Dedrick Rl, Myers Ce, Bungay Pm et al. · PubMed · 1978 · 743 citations
Leonard W. Seymour, Ruth Duncan, J. Strohalm et al. · Journal of Biomedical Materials Research · 1987 · 429 citations
Serena Deiana, Akihito Watanabe, Yuki Yamasaki et al. · Psychopharmacology · 2011 · 401 citations
Xiaozheng Ou, Haoran Wang, Huilin Tie et al. · Journal of Nanobiotechnology · 2023 · 200 citations · Full text
1–5 of 291
1.5K
5
h-index
4
h-index
4
h-index
3
h-index
3
h-index
1–5 of 1.5K
494
MedStar Washington Hospital Center
Washington D.C., United States
6 h-index
20 publications
1.4K citations
University of Illinois Urbana-Champaign
Urbana, United States
6 h-index
14 publications
312 citations

University of Toronto
Toronto, Canada
5 h-index
19 publications
539 citations
Inserm
Paris, France
4 h-index
19 publications
428 citations

Ghent University
Ghent, Belgium
4 h-index
23 publications
929 citations
Fudan University
Shanghai, China
3 h-index
6 publications
196 citations
University of Illinois Chicago
Chicago, United States
3 h-index
3 publications
289 citations
University of California, San Francisco
San Francisco, United States
3 h-index
11 publications
415 citations
1–8 of 494
Repository · 17 publications · 1.3K citations
14
h-index
13 publications · 650 citations
12
h-index
11 publications · 480 citations
11
h-index
PDI · 9 publications · 163 citations
9
h-index
JPP · 8 publications · 243 citations
8
h-index
1–5